Addressing COVID‐19 Drug Development with Artificial Intelligence

by Dean Ho
Published 2020-05-01

Nanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents

by Erik Pierstorff, Dean Ho
Published 2008-12-01

Nanodiamond and its application to drug delivery

by Eiji Osawa, Dean Ho
Published 2012-08-01

Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical Trial

by Benjamin Kye Jyn Tan, Chong Boon Teo, Xavier Tadeo, Xavier Tadeo, Xavier Tadeo, Siyu Peng, Hazel Pei Lin Soh, Sherry De Xuan Du, Vilianty Wen Ya Luo, Aishwarya Bandla, Raghav Sundar, Raghav Sundar, Raghav Sundar, Raghav Sundar, Raghav Sundar, Dean Ho, Dean Ho, Dean Ho, Dean Ho, Dean Ho, Theodore Wonpeum Kee, Theodore Wonpeum Kee, Theodore Wonpeum Kee, Agata Blasiak, Agata Blasiak, Agata Blasiak
Published 2021-04-01

IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development

by Agata Blasiak, Jhin Jieh Lim, Shirley Gek Kheng Seah, Theodore Kee, Alexandria Remus, De Hoe Chye, Pui San Wong, Lissa Hooi, Anh T. L. Truong, Nguyen Le, Conrad E. Z. Chan, Rishi Desai, Xianting Ding, Brendon J. Hanson, Edward Kai‐Hua Chow, Dean Ho
Published 2021-01-01